What are the Risks Associated with Thrombolytics in Cancer Patients?
While thrombolytics can be life-saving, their use in cancer patients comes with significant risks. The primary concern is the potential for severe bleeding, including intracranial hemorrhage. Cancer patients may have low platelet counts or other coagulation abnormalities, making them more susceptible to bleeding complications. Therefore, the benefits and risks must be carefully weighed before initiating thrombolytic therapy.
